Suketu Upadhyay's most recent trade in Vertex Pharmaceuticals, Inc. was a trade of 1,001 Common Stock done . Disclosure was reported to the exchange on May 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vertex Pharma | Suketu Upadhyay | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 May 2025 | 1,001 | 2,354 (0%) | 0% | - | Common Stock | |
| Vertex Pharma | Suketu Upadhyay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 1,001 | 2,475 | - | - | Deferred Stock Units | |
| Vertex Pharma | Suketu Upadhyay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 796 | 3,355 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Suketu Upadhyay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2025 | 71 | 1,474 | - | - | Deferred Stock Units | |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 4,560 | 50,882 (0%) | 0% | 0 | Common Stock | |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 4,560 | 4,559 | - | - | Restricted Stock Units | |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 104.86 per share. | 06 Mar 2025 | 2,029 | 48,853 (0%) | 0% | 104.9 | 212,761 | Common Stock |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 19,090 | 19,090 | - | - | Restricted Stock Units | |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 5,446 | 10,890 | - | - | Restricted Stock Units | |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 5,446 | 48,745 (0%) | 0% | 0 | Common Stock | |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.46 per share. | 20 Feb 2025 | 2,423 | 46,322 (0%) | 0% | 103.5 | 250,684 | Common Stock |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 21,622 | 51,454 (0%) | 0% | 0 | Common Stock | |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 21,622 | 0 | - | - | Restricted Stock Units | |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 21,622 | 21,622 | - | - | Restricted Stock Units | |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.00 per share. | 14 Feb 2025 | 8,155 | 43,299 (0%) | 0% | 101 | 823,655 | Common Stock |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2024 | 15,948 | 0 | - | - | Restricted Stock Units | |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2024 | 15,948 | 15,948 | - | - | Restricted Stock Units | |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2024 | 15,948 | 36,842 (0%) | 0% | 0 | Common Stock | |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 108.48 per share. | 08 Nov 2024 | 7,097 | 29,745 (0%) | 0% | 108.5 | 769,883 | Common Stock |
| Vertex Pharma | Suketu Upadhyay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 1,168 | 1,403 | - | - | Deferred Stock Units | |
| Vertex Pharma | Suketu Upadhyay | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 May 2024 | 1,168 | 2,559 (0%) | 0% | - | Common Stock | |
| Vertex Pharma | Suketu Upadhyay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 1,001 | 3,727 (0%) | 0% | 0 | Common Stock | |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2024 | 4,561 | 9,119 | - | - | Restricted Stock Units | |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2024 | 4,561 | 22,683 (0%) | 0% | 0 | Common Stock | |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 125.82 per share. | 06 Mar 2024 | 1,919 | 20,764 (0%) | 0% | 125.8 | 241,449 | Common Stock |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2024 | 7,043 | 20,213 (0%) | 0% | 0 | Common Stock | |
| Zimmer Biomet | Upadhyay Suketu | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2024 | 7,043 | 0 | - | - | Restricted Stock Units | |
| Zimmer Biomet | Upadhyay Suketu | Exec. VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 128.80 per share. | 25 Feb 2024 | 2,091 | 18,122 (0%) | 0% | 128.8 | 269,321 | Common Stock |
| Zimmer Biomet | Upadhyay Suketu | Exec. VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 16,336 | 16,336 | - | - | Restricted Stock Units | |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2023 | 3,768 | 14,660 (0%) | 0% | 0 | Common Stock | |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2023 | 3,768 | 0 | - | - | Restricted Stock Units | |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 146.51 per share. | 01 Jul 2023 | 1,677 | 12,983 (0%) | 0% | 146.5 | 245,697 | Common Stock |
| Vertex Pharma | Suketu Upadhyay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2023 | 1,168 | 2,726 (0%) | 0% | 0 | Common Stock | |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 13,680 | 13,680 | - | - | Restricted Stock Units | |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2023 | 3,860 | 0 | - | - | Restricted Stock Units | |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2023 | 3,860 | 12,047 (0%) | 0% | 0 | Common Stock | |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 124.73 per share. | 21 Feb 2023 | 1,155 | 10,892 (0%) | 0% | 124.7 | 144,063 | Common Stock |
| Vertex Pharma | Suketu Upadhyay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2023 | 96 | 235 | - | - | Deferred Stock Units | |
| Vertex Pharma | Suketu Upadhyay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Oct 2022 | 96 | 138 | - | - | Deferred Stock Units | |
| Vertex Pharma | Suketu Upadhyay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2022 | 41 | 41 | - | - | Deferred Stock Units | |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2022 | 3,768 | 9,231 (0%) | 0% | 0 | Common Stock | |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2022 | 3,768 | 3,768 | - | - | Restricted Stock Units | |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.85 per share. | 01 Jul 2022 | 1,249 | 7,982 (0%) | 0% | 105.9 | 132,207 | Common Stock |
| Vertex Pharma | Suketu Upadhyay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 1,558 | 1,558 (0%) | 0% | 0 | Common Stock | |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 6,831 | 6,831 | - | - | Restricted Stock Units | |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 3,744 | 3,744 | - | - | Restricted Stock Units | |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 50,046 | 50,046 | - | - | Employee Stock Option (right to buy) | |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2021 | 3,655 | 6,416 (0%) | 0% | 0 | Common Stock | |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2021 | 3,655 | 7,310 | - | - | Restricted Stock Units | |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 161.94 per share. | 01 Jul 2021 | 1,112 | 5,304 (0%) | 0% | 161.9 | 180,077 | Common Stock |
| Zimmer Biomet | Suketu Upadhyay | Exec. VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 33,914 | 33,914 | - | - | Employee Stock Option (right to buy) |